Shah Rajeev M.

Director, 10% OwnerVor Biopharma Inc. (VOR) · full profile →Form 4 · filed Oct 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13.7M
Net Open-Market Flow
-$13.7M
Transactions
16
16 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 17, 2025Sell(S)2K$31.00$77K15K
Oct 17, 2025Sell(S)34K$29.12$998K24K
Oct 17, 2025Sell(S)175K$29.12$5.1M1.5M
Oct 17, 2025Sell(S)31K$30.28$931K1.5M
Oct 17, 2025Sell(S)6K$30.28$183K18K
Oct 17, 2025Sell(S)13K$31.00$393K1.5M
Oct 16, 2025Sell(S)16K$30.36$480K1.7M
Oct 16, 2025Sell(S)111K$29.32$3.3M1.7M
Oct 16, 2025Sell(S)4$31.35$12558K
Oct 16, 2025Sell(S)20$31.35$6271.7M
Oct 16, 2025Sell(S)3K$30.36$94K58K
Oct 16, 2025Sell(S)22K$29.32$639K61K
Oct 15, 2025Sell(S)234$31.17$7K1.8M
Oct 15, 2025Sell(S)43K$30.55$1.3M1.8M
Oct 15, 2025Sell(S)46$31.17$1K83K
Oct 15, 2025Sell(S)8K$30.55$256K83K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-25-000333) within minutes of acceptance. Every field above traces to the original document. Verify it directly: